APO Research, Inc.

APO RESEARCH · REPORT

Multispectral Imaging for Skin Disease

Selected research

Market Structure

Global Multispectral Imaging for Skin Disease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Multispectral Imaging for Skin Disease market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Multispectral Imaging for Skin Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Multispectral Imaging for Skin Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multispectral Imaging for Skin Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Multispectral Imaging for Skin Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Multispectral Imaging for Skin Disease include DermLite, ViseoMed, Optovue, Navitar, E-con Systems, Caliber, Emage Medical LLC, Courage + Khazaka Electronic and Longport Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Multispectral Imaging for Skin Disease market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Multispectral Imaging for Skin Disease and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Multispectral Imaging for Skin Disease revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Multispectral Imaging for Skin Disease market size, projected growth trends, production technologies, key applications, and end-use industries.

Multispectral Imaging for Skin Disease Segment by Company

DermLite

ViseoMed

Optovue

Navitar

E-con Systems

Caliber

Emage Medical LLC

Courage + Khazaka Electronic

Longport Inc.

Cortex Technology

Atys Medical

Multispectral Imaging for Skin Disease Segment by Type

Digital Photographic Imaging

Dermoscopy

Others

Multispectral Imaging for Skin Disease Segment by Application

Pigmented Lesions

Psoriasis

Skin Cancer

Plastic and Reconstructive Surgery

Other

Multispectral Imaging for Skin Disease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multispectral Imaging for Skin Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multispectral Imaging for Skin Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multispectral Imaging for Skin Disease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Multispectral Imaging for Skin Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Multispectral Imaging for Skin Disease industry.

Chapter 3: Detailed analysis of Multispectral Imaging for Skin Disease companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Multispectral Imaging for Skin Diseaserevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Multispectral Imaging for Skin Disease Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Digital Photographic Imaging Table 3. Key Players of Dermoscopy Table 4. Key Players of Others Table 4. Global Multispectral Imaging for Skin Disease Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pigmented Lesions Table 6. Key Players of Psoriasis Table 7. Key Players of Skin Cancer Table 8. Key Players of Plastic and Reconstructive Surgery Table 9. Key Players of Other Table 10. Global Multispectral Imaging for Skin Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Multispectral Imaging for Skin Disease Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Multispectral Imaging for Skin Disease Market Share by Region (2021-2026) Table 13. Global Multispectral Imaging for Skin Disease Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Multispectral Imaging for Skin Disease Market Share by Region (2027-2032) Table 15. Multispectral Imaging for Skin Disease Industry Trends Table 16. Multispectral Imaging for Skin Disease Industry Drivers Table 17. Multispectral Imaging for Skin Disease Industry Opportunities and Challenges Table 18. Multispectral Imaging for Skin Disease Industry Restraints Table 19. Global Multispectral Imaging for Skin Disease Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Multispectral Imaging for Skin Disease Revenue Market Share by Company (2021-2026) Table 21. Global Multispectral Imaging for Skin Disease Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Multispectral Imaging for Skin Disease Key Company Head Office and Area Served Table 23. Global Multispectral Imaging for Skin Disease Company, Product Type & Application Table 24. Global Multispectral Imaging for Skin Disease Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Multispectral Imaging for Skin Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Multispectral Imaging for Skin Disease Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Multispectral Imaging for Skin Disease Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Multispectral Imaging for Skin Disease Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Multispectral Imaging for Skin Disease Revenue Market Share by Type (2021-2026) Table 31. Global Multispectral Imaging for Skin Disease Revenue Market Share by Type (2027-2032) Table 32. Global Multispectral Imaging for Skin Disease Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Multispectral Imaging for Skin Disease Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Multispectral Imaging for Skin Disease Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Multispectral Imaging for Skin Disease Revenue Market Share by Application (2021-2026) Table 36. Global Multispectral Imaging for Skin Disease Revenue Market Share by Application (2027-2032) Table 37. DermLite Company Information Table 38. DermLite Business Overview Table 39. DermLite Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. DermLite Multispectral Imaging for Skin Disease Product Portfolio Table 41. DermLite Recent Development Table 42. ViseoMed Company Information Table 43. ViseoMed Business Overview Table 44. ViseoMed Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. ViseoMed Multispectral Imaging for Skin Disease Product Portfolio Table 46. ViseoMed Recent Development Table 47. Optovue Company Information Table 48. Optovue Business Overview Table 49. Optovue Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Optovue Multispectral Imaging for Skin Disease Product Portfolio Table 51. Optovue Recent Development Table 52. Navitar Company Information Table 53. Navitar Business Overview Table 54. Navitar Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Navitar Multispectral Imaging for Skin Disease Product Portfolio Table 56. Navitar Recent Development Table 57. E-con Systems Company Information Table 58. E-con Systems Business Overview Table 59. E-con Systems Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. E-con Systems Multispectral Imaging for Skin Disease Product Portfolio Table 61. E-con Systems Recent Development Table 62. Caliber Company Information Table 63. Caliber Business Overview Table 64. Caliber Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Caliber Multispectral Imaging for Skin Disease Product Portfolio Table 66. Caliber Recent Development Table 67. Emage Medical LLC Company Information Table 68. Emage Medical LLC Business Overview Table 69. Emage Medical LLC Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Emage Medical LLC Multispectral Imaging for Skin Disease Product Portfolio Table 71. Emage Medical LLC Recent Development Table 72. Courage + Khazaka Electronic Company Information Table 73. Courage + Khazaka Electronic Business Overview Table 74. Courage + Khazaka Electronic Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Courage + Khazaka Electronic Multispectral Imaging for Skin Disease Product Portfolio Table 76. Courage + Khazaka Electronic Recent Development Table 77. Longport Inc. Company Information Table 78. Longport Inc. Business Overview Table 79. Longport Inc. Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Longport Inc. Multispectral Imaging for Skin Disease Product Portfolio Table 81. Longport Inc. Recent Development Table 82. Cortex Technology Company Information Table 83. Cortex Technology Business Overview Table 84. Cortex Technology Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Cortex Technology Multispectral Imaging for Skin Disease Product Portfolio Table 86. Cortex Technology Recent Development Table 87. Atys Medical Company Information Table 88. Atys Medical Business Overview Table 89. Atys Medical Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Atys Medical Multispectral Imaging for Skin Disease Product Portfolio Table 91. Atys Medical Recent Development Table 92. North America Multispectral Imaging for Skin Disease Market Size by Type (2021-2026) & (US$ Million) Table 93. North America Multispectral Imaging for Skin Disease Market Size by Type (2027-2032) & (US$ Million) Table 94. North America Multispectral Imaging for Skin Disease Market Size by Application (2021-2026) & (US$ Million) Table 95. North America Multispectral Imaging for Skin Disease Market Size by Application (2027-2032) & (US$ Million) Table 96. North America Multispectral Imaging for Skin Disease Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Multispectral Imaging for Skin Disease Market Size by Country (2021-2026) Table 98. North America Multispectral Imaging for Skin Disease Market Size by Country (2027-2032) Table 99. Europe Multispectral Imaging for Skin Disease Market Size by Type (2021-2026) & (US$ Million) Table 100. Europe Multispectral Imaging for Skin Disease Market Size by Type (2027-2032) & (US$ Million) Table 101. Europe Multispectral Imaging for Skin Disease Market Size by Application (2021-2026) & (US$ Million) Table 102. Europe Multispectral Imaging for Skin Disease Market Size by Application (2027-2032) & (US$ Million) Table 103. Europe Multispectral Imaging for Skin Disease Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Multispectral Imaging for Skin Disease Market Size by Country (2021-2026) Table 105. Europe Multispectral Imaging for Skin Disease Market Size by Country (2027-2032) Table 106. China Multispectral Imaging for Skin Disease Market Size by Type (2021-2026) & (US$ Million) Table 107. China Multispectral Imaging for Skin Disease Market Size by Type (2027-2032) & (US$ Million) Table 108. China Multispectral Imaging for Skin Disease Market Size by Application (2021-2026) & (US$ Million) Table 109. China Multispectral Imaging for Skin Disease Market Size by Application (2027-2032) & (US$ Million) Table 110. Asia Multispectral Imaging for Skin Disease Market Size by Type (2021-2026) & (US$ Million) Table 111. Asia Multispectral Imaging for Skin Disease Market Size by Type (2027-2032) & (US$ Million) Table 112. Asia Multispectral Imaging for Skin Disease Market Size by Application (2021-2026) & (US$ Million) Table 113. Asia Multispectral Imaging for Skin Disease Market Size by Application (2027-2032) & (US$ Million) Table 114. Asia Multispectral Imaging for Skin Disease Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Asia Multispectral Imaging for Skin Disease Market Size by Country (2021-2026) Table 116. Asia Multispectral Imaging for Skin Disease Market Size by Country (2027-2032) Table 117. South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Type (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Type (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Application (2021-2026) & (US$ Million) Table 120. South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Application (2027-2032) & (US$ Million) Table 121. South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Country (2021-2026) Table 123. South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Country (2027-2032) Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Multispectral Imaging for Skin Disease Product Image Figure 2. Global Multispectral Imaging for Skin Disease Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Multispectral Imaging for Skin Disease Market Share by Type: 2025 VS 2032 Figure 4. Digital Photographic Imaging Image Figure 5. Dermoscopy Image Figure 6. Others Image Figure 7. Global Multispectral Imaging for Skin Disease Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Multispectral Imaging for Skin Disease Market Share by Application: 2025 VS 2032 Figure 9. Pigmented Lesions Image Figure 10. Psoriasis Image Figure 11. Skin Cancer Image Figure 12. Plastic and Reconstructive Surgery Image Figure 13. Other Image Figure 14. Global Multispectral Imaging for Skin Disease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 16. Global Multispectral Imaging for Skin Disease Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Multispectral Imaging for Skin Disease Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Multispectral Imaging for Skin Disease Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Multispectral Imaging for Skin Disease Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Multispectral Imaging for Skin Disease Revenue Market Share by Type (2021-2032) Figure 23. Global Multispectral Imaging for Skin Disease Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Multispectral Imaging for Skin Disease Revenue Market Share by Application (2021-2032) Figure 25. North America Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 26. North America Multispectral Imaging for Skin Disease Market Share by Type (2021-2032) Figure 27. North America Multispectral Imaging for Skin Disease Market Share by Application (2021-2032) Figure 28. North America Multispectral Imaging for Skin Disease Market Share by Country (2021-2032) Figure 29. United States Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 30. Canada Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 32. Europe Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 33. Europe Multispectral Imaging for Skin Disease Market Share by Type (2021-2032) Figure 34. Europe Multispectral Imaging for Skin Disease Market Share by Application (2021-2032) Figure 35. Europe Multispectral Imaging for Skin Disease Market Share by Country (2021-2032) Figure 36. Germany Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 37. France Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 39. Italy Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 40. Russia Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 42. China Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 43. China Multispectral Imaging for Skin Disease Market Share by Type (2021-2032) Figure 44. China Multispectral Imaging for Skin Disease Market Share by Application (2021-2032) Figure 45. Asia Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 46. Asia Multispectral Imaging for Skin Disease Market Share by Type (2021-2032) Figure 47. Asia Multispectral Imaging for Skin Disease Market Share by Application (2021-2032) Figure 48. Asia Multispectral Imaging for Skin Disease Market Share by Country (2021-2032) Figure 49. Japan Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 53. India Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 54. Australia Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Share by Country (2021-2032) Figure 59. Brazil Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 64. UAE Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 66. Chile Multispectral Imaging for Skin Disease Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Digital Photographic Imaging
  • Dermoscopy
  • Others
Applications
  • Pigmented Lesions
  • Psoriasis
  • Skin Cancer
  • Plastic and Reconstructive Surgery
  • Other
Companies covered
  • DermLite
  • ViseoMed
  • Optovue
  • Navitar
  • E-con Systems
  • Caliber
  • Emage Medical LLC
  • Courage + Khazaka Electronic
  • Longport Inc.
  • Cortex Technology
  • Atys Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Multispectral Imaging for Skin Disease Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Digital Photographic Imaging
  5. 1.2.3 Dermoscopy
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Multispectral Imaging for Skin Disease Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Pigmented Lesions
  10. 1.3.3 Psoriasis
  11. 1.3.4 Skin Cancer
  12. 1.3.5 Plastic and Reconstructive Surgery
  13. 1.3.6 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Multispectral Imaging for Skin Disease Growth Trends by Region
  16. 1.5.1 Global Multispectral Imaging for Skin Disease Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Multispectral Imaging for Skin Disease Market Size by Region (2021-2026)
  18. 1.5.3 Multispectral Imaging for Skin Disease Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Multispectral Imaging for Skin Disease Market Dynamics
  1. 2.1 Multispectral Imaging for Skin Disease Industry Trends
  2. 2.2 Multispectral Imaging for Skin Disease Industry Drivers
  3. 2.3 Multispectral Imaging for Skin Disease Industry Opportunities and Challenges
  4. 2.4 Multispectral Imaging for Skin Disease Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Multispectral Imaging for Skin Disease Revenue by Company (2021-2026)
  2. 3.2 Global Multispectral Imaging for Skin Disease Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Multispectral Imaging for Skin Disease Key Company Head office and Area Served
  4. 3.4 Global Multispectral Imaging for Skin Disease Company, Product Type & Application
  5. 3.5 Global Multispectral Imaging for Skin Disease Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Multispectral Imaging for Skin Disease Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Multispectral Imaging for Skin Disease Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Multispectral Imaging for Skin Disease Tier 1, Tier 2, and Tier 3
4 Multispectral Imaging for Skin Disease Market by Type
  1. 4.1 Global Multispectral Imaging for Skin Disease Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Multispectral Imaging for Skin Disease Market Size by Type (2021-2032)
  3. 4.3 Global Multispectral Imaging for Skin Disease Market Size Share by Type (2021-2032)
5 Multispectral Imaging for Skin Disease Market by Application
  1. 5.1 Global Multispectral Imaging for Skin Disease Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Multispectral Imaging for Skin Disease Market Size by Application (2021-2032)
  3. 5.3 Global Multispectral Imaging for Skin Disease Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 DermLite
  2. 6.1.1 DermLite Company Information
  3. 6.1.2 DermLite Business Overview
  4. 6.1.3 DermLite Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 DermLite Multispectral Imaging for Skin Disease Product Portfolio
  6. 6.1.5 DermLite Recent Developments
  7. 6.2 ViseoMed
  8. 6.2.1 ViseoMed Company Information
  9. 6.2.2 ViseoMed Business Overview
  10. 6.2.3 ViseoMed Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 ViseoMed Multispectral Imaging for Skin Disease Product Portfolio
  12. 6.2.5 ViseoMed Recent Developments
  13. 6.3 Optovue
  14. 6.3.1 Optovue Company Information
  15. 6.3.2 Optovue Business Overview
  16. 6.3.3 Optovue Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Optovue Multispectral Imaging for Skin Disease Product Portfolio
  18. 6.3.5 Optovue Recent Developments
  19. 6.4 Navitar
  20. 6.4.1 Navitar Company Information
  21. 6.4.2 Navitar Business Overview
  22. 6.4.3 Navitar Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Navitar Multispectral Imaging for Skin Disease Product Portfolio
  24. 6.4.5 Navitar Recent Developments
  25. 6.5 E-con Systems
  26. 6.5.1 E-con Systems Company Information
  27. 6.5.2 E-con Systems Business Overview
  28. 6.5.3 E-con Systems Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 E-con Systems Multispectral Imaging for Skin Disease Product Portfolio
  30. 6.5.5 E-con Systems Recent Developments
  31. 6.6 Caliber
  32. 6.6.1 Caliber Company Information
  33. 6.6.2 Caliber Business Overview
  34. 6.6.3 Caliber Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Caliber Multispectral Imaging for Skin Disease Product Portfolio
  36. 6.6.5 Caliber Recent Developments
  37. 6.7 Emage Medical LLC
  38. 6.7.1 Emage Medical LLC Company Information
  39. 6.7.2 Emage Medical LLC Business Overview
  40. 6.7.3 Emage Medical LLC Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Emage Medical LLC Multispectral Imaging for Skin Disease Product Portfolio
  42. 6.7.5 Emage Medical LLC Recent Developments
  43. 6.8 Courage + Khazaka Electronic
  44. 6.8.1 Courage + Khazaka Electronic Company Information
  45. 6.8.2 Courage + Khazaka Electronic Business Overview
  46. 6.8.3 Courage + Khazaka Electronic Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Courage + Khazaka Electronic Multispectral Imaging for Skin Disease Product Portfolio
  48. 6.8.5 Courage + Khazaka Electronic Recent Developments
  49. 6.9 Longport Inc.
  50. 6.9.1 Longport Inc. Company Information
  51. 6.9.2 Longport Inc. Business Overview
  52. 6.9.3 Longport Inc. Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Longport Inc. Multispectral Imaging for Skin Disease Product Portfolio
  54. 6.9.5 Longport Inc. Recent Developments
  55. 6.10 Cortex Technology
  56. 6.10.1 Cortex Technology Company Information
  57. 6.10.2 Cortex Technology Business Overview
  58. 6.10.3 Cortex Technology Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Cortex Technology Multispectral Imaging for Skin Disease Product Portfolio
  60. 6.10.5 Cortex Technology Recent Developments
  61. 6.11 Atys Medical
  62. 6.11.1 Atys Medical Company Information
  63. 6.11.2 Atys Medical Business Overview
  64. 6.11.3 Atys Medical Multispectral Imaging for Skin Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Atys Medical Multispectral Imaging for Skin Disease Product Portfolio
  66. 6.11.5 Atys Medical Recent Developments
7 North America
  1. 7.1 North America Multispectral Imaging for Skin Disease Market Size (2021-2032)
  2. 7.2 North America Multispectral Imaging for Skin Disease Market Size by Type
  3. 7.2.1 North America Multispectral Imaging for Skin Disease Market Size by Type (2021-2026)
  4. 7.2.2 North America Multispectral Imaging for Skin Disease Market Size by Type (2027-2032)
  5. 7.2.3 North America Multispectral Imaging for Skin Disease Market Share by Type (2021-2032)
  6. 7.3 North America Multispectral Imaging for Skin Disease Market Size by Application
  7. 7.3.1 North America Multispectral Imaging for Skin Disease Market Size by Application (2021-2026)
  8. 7.3.2 North America Multispectral Imaging for Skin Disease Market Size by Application (2027-2032)
  9. 7.3.3 North America Multispectral Imaging for Skin Disease Market Share by Application (2021-2032)
  10. 7.4 North America Multispectral Imaging for Skin Disease Market Size by Country
  11. 7.4.1 North America Multispectral Imaging for Skin Disease Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Multispectral Imaging for Skin Disease Market Size by Country (2021-2026)
  13. 7.4.3 North America Multispectral Imaging for Skin Disease Market Size by Country (2027-2032)
  14. 7.4.4 North America Multispectral Imaging for Skin Disease Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Multispectral Imaging for Skin Disease Market Size (2021-2032)
  2. 8.2 Europe Multispectral Imaging for Skin Disease Market Size by Type
  3. 8.2.1 Europe Multispectral Imaging for Skin Disease Market Size by Type (2021-2026)
  4. 8.2.2 Europe Multispectral Imaging for Skin Disease Market Size by Type (2027-2032)
  5. 8.2.3 Europe Multispectral Imaging for Skin Disease Market Share by Type (2021-2032)
  6. 8.3 Europe Multispectral Imaging for Skin Disease Market Size by Application
  7. 8.3.1 Europe Multispectral Imaging for Skin Disease Market Size by Application (2021-2026)
  8. 8.3.2 Europe Multispectral Imaging for Skin Disease Market Size by Application (2027-2032)
  9. 8.3.3 Europe Multispectral Imaging for Skin Disease Market Share by Application (2021-2032)
  10. 8.4 Europe Multispectral Imaging for Skin Disease Market Size by Country
  11. 8.4.1 Europe Multispectral Imaging for Skin Disease Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Multispectral Imaging for Skin Disease Market Size by Country (2021-2026)
  13. 8.4.3 Europe Multispectral Imaging for Skin Disease Market Size by Country (2027-2032)
  14. 8.4.4 Europe Multispectral Imaging for Skin Disease Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Multispectral Imaging for Skin Disease Market Size (2021-2032)
  2. 9.2 China Multispectral Imaging for Skin Disease Market Size by Type
  3. 9.2.1 China Multispectral Imaging for Skin Disease Market Size by Type (2021-2026)
  4. 9.2.2 China Multispectral Imaging for Skin Disease Market Size by Type (2027-2032)
  5. 9.2.3 China Multispectral Imaging for Skin Disease Market Share by Type (2021-2032)
  6. 9.3 China Multispectral Imaging for Skin Disease Market Size by Application
  7. 9.3.1 China Multispectral Imaging for Skin Disease Market Size by Application (2021-2026)
  8. 9.3.2 China Multispectral Imaging for Skin Disease Market Size by Application (2027-2032)
  9. 9.3.3 China Multispectral Imaging for Skin Disease Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Multispectral Imaging for Skin Disease Market Size (2021-2032)
  2. 10.2 Asia Multispectral Imaging for Skin Disease Market Size by Type
  3. 10.2.1 Asia Multispectral Imaging for Skin Disease Market Size by Type (2021-2026)
  4. 10.2.2 Asia Multispectral Imaging for Skin Disease Market Size by Type (2027-2032)
  5. 10.2.3 Asia Multispectral Imaging for Skin Disease Market Share by Type (2021-2032)
  6. 10.3 Asia Multispectral Imaging for Skin Disease Market Size by Application
  7. 10.3.1 Asia Multispectral Imaging for Skin Disease Market Size by Application (2021-2026)
  8. 10.3.2 Asia Multispectral Imaging for Skin Disease Market Size by Application (2027-2032)
  9. 10.3.3 Asia Multispectral Imaging for Skin Disease Market Share by Application (2021-2032)
  10. 10.4 Asia Multispectral Imaging for Skin Disease Market Size by Country
  11. 10.4.1 Asia Multispectral Imaging for Skin Disease Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Multispectral Imaging for Skin Disease Market Size by Country (2021-2026)
  13. 10.4.3 Asia Multispectral Imaging for Skin Disease Market Size by Country (2027-2032)
  14. 10.4.4 Asia Multispectral Imaging for Skin Disease Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Multispectral Imaging for Skin Disease Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.